Generis Partner with Cognizant to Deliver Information Management and Structured Content Authoring
This partnership will see Cognizant leverage Generis' flagship product, the CARA Life Science Platform, to enable clients to streamline their business processes on one comprehensive Workspace that covers: RIM / Regulatory and Quality / QMS and Safety / PV and Clinical, as well as enterprise-wide functionality such as Component-Based / Structured Content Authoring.
CARA is an innovative enterprise workspace designed specifically for Life Sciences which offers a simple, unified way of working with business-critical content and information.
"We are delighted to be working with such a forward-thinking organisation. Cognizant understands the business problems that our mutual customers face, and how to address those in a way that goes beyond the standard IT implementation partner approach", said James Kelleher, CEO of Generis. "This strategic partnership will enable our existing and new customers to make the most of the possibilities within the CARA platform."
CARA is already widely deployed in the pharmaceutical, biotech, medical device, and other industries where strict regulatory compliance must be maintained.
Customers include 60% of the Top 20 largest life science companies as well as over 500,000 users globally.
Generis is a global leader in information management systems, specialising in proven solutions for regulated industries. Our mission is to provide a system which is seamless and user-friendly;
Find out more at: https://www.generiscorp.com
Cognizant is one of the world's leading professional services companies, transforming clients' business, operating, and technology models for the digital era. Our unique industry-based, consultative approach helps clients envision, build and run more innovative and efficient businesses. Headquartered in the U.S., Cognizant is ranked 194 on the Fortune 500 and is consistently listed among the most admired companies in the world. Learn how Cognizant helps clients lead with digital at www.cognizant.com or follow us @Cognizant.